Global Wormer Testing Rules Now Include Pigs Too
Published Date: 6/24/2026
Notice
Summary
The FDA just released new guidance to help vets and drug makers test worm-killing medicines for pigs. This makes it easier to get these medicines approved worldwide by using the same testing rules. If you work with pig medicines, start following these recommendations now to save time and money on approvals.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Porcine Anthelmintic Study Guidelines
The FDA published final Guidance for Industry (GFI #110) on June 24, 2026 that gives study-design recommendations for testing worm‑killing (anthelmintic) drugs for pigs. The guidance is meant to help regulators in the United States, the European Union, and Japan accept the same effectiveness data so manufacturers can meet national or regional approval requirements.
Guidance Is Non‑Binding Flexibility
The FDA states this guidance does not establish any rights and is not binding. You may use an alternative approach if it satisfies the requirements of the applicable statutes and regulations.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12621 — Expedited Investigational New Drug Pilot Program; Request for Information
The FDA wants to speed up how fast new drugs get tested on people by creating a special pilot program. This program will team up trusted research groups with drug makers to review early study plans faster, while keeping safety top priority. If you’re involved in drug research or healthcare, now’s your chance to share ideas before July 22, 2026!
2026-12620 — Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability
The FDA just dropped a fresh draft guidance to help drug and biological product makers run smarter, faster clinical trials using master protocols. This update affects companies developing new medicines by clarifying how to design and submit these trials for approval. If you’re in the game, get your comments in by August 24, 2026, or risk missing out on shaping the final rules—and maybe saving time and money down the road!
2026-12679 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Bovines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for cows. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping cattle healthy. Farmers, vets, and drug companies should watch for these changes starting now—no extra costs, just clearer rules!
2026-12681 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Caprines; Guidance for Industry; Availability
The FDA just released new guidance to help drug makers prove their worm-killing medicines work well in goats. This makes it easier for companies worldwide to get their products approved by following the same rules. Goat farmers, vets, and drug companies should watch for these updates starting June 24, 2026, which could speed up getting effective treatments to animals without extra costs.
2026-12622 — Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Revised Draft Guidance for Industry; Availability
The FDA just released a new draft guide to help drug makers prove their medicines really work, using smarter and faster science. This update affects companies developing human drugs and biological products, aiming to save time and money by allowing strong evidence from just one good clinical study plus extra proof. Comments on this draft are open until September 22, 2026, so industry folks have a chance to weigh in before it becomes final.
2026-12685 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability
The FDA just released new guidance to help vets and drug makers prove how well deworming medicines work for cats. This makes it easier to get these medicines approved worldwide by using the same testing rules. If you’re in the pet medicine business, this update helps speed up approvals and keeps our feline friends healthier—starting now!
Previous / Next Documents
Previous: 2026-12682 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Equines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for horses. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping horses healthy. If you’re in the veterinary or animal medicine world, this update is your new go-to starting June 24, 2026.
Next: 2026-12684 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Canines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for dogs. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping pups healthier. If you’re in the veterinary medicine business, this update could save time and money starting now!